Pancreatic Cancer Research

ResearcherNational Cancer Centre JapanActive in the last 2 years

Mami Takahashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5062-811X; OpenAlex author ID A5063218521. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 9

  1. MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218348↗
  2. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells. Co-author DOI 10.1080/01635581.2020.1863994↗
  3. Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from an N-Nitrosobis(2-oxopropyl)amine-initiated Syrian Golden Hamster Pancreatic Carcinogene… Last author DOI 10.21873/cgp.20268↗
  4. [Possibility of Pancreatic Cancer Chemoprevention by Anti-Inflammatory/Anti-Diabetic/Anti-Dyslipidemic Drugs]. Co-author PMID 34911905↗
  5. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Co-author DOI 10.1111/cas.13766↗
  6. Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects. Co-author DOI 10.1186/s12876-016-0503-7↗
  7. Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese. Co-author DOI 10.1038/srep17018↗
  8. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma. First author DOI 10.1038/ctg.2014.5↗
  9. Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in Japan. Co-author DOI 10.7314/apjcp.2014.15.1.391↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michihiro Mutoh · 4 shared papers, 2014–2022 · strength 0.40
  2. Masaru Terasaki · 2 shared papers, 2021–2022 · strength 0.26
  3. Nobuyoshi Hiraoka · 2 shared papers, 2014–2026 · strength 0.24
  4. Keisuke Sekine · 1 shared paper, 2026 · strength 0.20
  5. Kazunori Aoki · 1 shared paper, 2026 · strength 0.20
  6. Satoshi Nara · 1 shared paper, 2026 · strength 0.20
  7. Hiroyuki Tsunoda · 1 shared paper, 2026 · strength 0.20
  8. Hironori Fukuda · 1 shared paper, 2026 · strength 0.20
  9. Minoru Esaki · 1 shared paper, 2026 · strength 0.20
  10. Atsushi Ochiai · 1 shared paper, 2026 · strength 0.20
  11. Kazuaki Shimada · 4 shared papers, 2014–2016 · strength 0.15
  12. Yasuhiro Kuramitsu · 1 shared paper, 2022 · strength 0.14
  13. Hitoshi Nakagama · 2 shared papers, 2014–2018 · strength 0.14
  14. Mika Hori · 2 shared papers, 2014–2018 · strength 0.14
  15. Shinichi Ohkawa · 3 shared papers, 2014–2016 · strength 0.11
  16. Kozue Nakamura · 3 shared papers, 2014–2016 · strength 0.11
  17. Naoto Egawa · 3 shared papers, 2014–2016 · strength 0.11
  18. Hiroshi Ishii · 3 shared papers, 2014–2016 · strength 0.11
  19. Sawako Kuruma · 3 shared papers, 2014–2016 · strength 0.11
  20. Yingsong Lin · 3 shared papers, 2014–2016 · strength 0.11
  21. Haruhisa Nakao · 3 shared papers, 2014–2016 · strength 0.11
  22. Masato Matsuyama · 3 shared papers, 2014–2016 · strength 0.11
  23. Makoto Ueno · 3 shared papers, 2014–2016 · strength 0.11
  24. Keitaro Matsuo · 3 shared papers, 2014–2016 · strength 0.11
  25. Shogo Kikuchi · 3 shared papers, 2014–2016 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.